FBS and Animal Sera for Viral Vaccine Production
Viral vaccine manufacturing relies on consistent, high-quality serum to support the propagation of Vero, MDCK, BHK-21, and other substrate cell lines used for influenza, rabies, polio, and emerging pathogen vaccines. Serum quality directly impacts cell growth rates, virus yield, and downstream purification efficiency. Regulatory expectations for serum used in vaccine manufacturing — particularly regarding origin, adventitious agent testing, and traceability — are among the most stringent in the biologicals industry.
SeamlessBio supplies FBS and specialty animal sera for vaccine production applications, with EU-origin material, gamma irradiation on request, and batch reservation for continuous manufacturing campaigns.
Key Products for Vaccine Manufacturing
| Product | Specification | Vaccine Application |
|---|---|---|
| FBS Low Endotoxin | <1 EU/mL | Vero, MDCK, BHK-21 cell maintenance and virus propagation |
| FBS Gamma Irradiated | ≥25 kGy irradiation | BSL-2/3 containment applications; enhanced adventitious agent risk reduction |
| FBS — EU Origin | Sourced from EU-approved herds | EMA-compliant sourcing for EU-manufactured vaccines; reduced TSE risk documentation |
| Horse Serum | Standard and Donor Horse Serum (DHS) | MRC-5 and WI-38 cell maintenance; some viral vaccine substrates |
| Bovine Serum (non-FBS grades) | Various specifications | Cost-efficient substrate cell maintenance in large-scale bioreactor culture |
Regulatory Considerations for Serum in Vaccine Manufacturing
Serum used in vaccine manufacturing is subject to specific regulatory requirements under EMA guidelines (EMEA/CHMP/BWP/457920/2012) and WHO Technical Report Series recommendations. Key documentation requirements include:
- Geographic origin certification — EU-origin FBS provides the most straightforward TSE risk documentation for EMA submissions
- Adventitious agent testing — BVDV, mycoplasma, sterility per EP and USP requirements; lot-specific test reports available
- Gamma irradiation certificate — for applications requiring enhanced biosafety margins; irradiation certificates with dose mapping available on request
- Batch traceability — full lot-to-herd traceability documentation for GMP and regulatory submissions
Batch Reservation for Continuous Manufacturing
Vaccine manufacturing campaigns require serum lots large enough to cover extended production runs without lot changes. SeamlessBio offers batch reservation for vaccine manufacturers — securing a dedicated lot volume from initial cell banking through final bulk harvest. This eliminates the risk of mid-campaign lot changes and supports consistent virus yield data across regulatory submission batches.
→ View FBS grades at shop.seamlessbio.de
→ Gamma irradiation, batch reservation, and bulk supply enquiries: info@seamlessbio.de | +49 851 37932226